Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEORAD: Everolimus in Advanced RCC
NCT01715935Phase 2Completed
- Sponsor
- ARTIC
- Start
- Jun 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in renal cell carcinoma (RCC), sponsored by ARTIC. Started Jun 2012; status: completed.
02
Drugs
everolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01715935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01715935.